Charlotte's Web Holdings Inc

OTCQX:CWBHF USA Drug Manufacturers - Specialty & Generic
Market Cap
$12.75 Million
Market Cap Rank
#29025 Global
#9636 in USA
Share Price
$0.08
Change (1 day)
-10.11%
52-Week Range
$0.08 - $0.11
All Time High
$24.05
About

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. Its product categories include full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushrooms; and pet products u… Read more

Charlotte's Web Holdings Inc (CWBHF) - Net Assets

Latest net assets as of September 2025: $9.25 Million USD

Based on the latest financial reports, Charlotte's Web Holdings Inc (CWBHF) has net assets worth $9.25 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($81.60 Million) and total liabilities ($72.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $9.25 Million
% of Total Assets 11.33%
Annual Growth Rate 24.46%
5-Year Change -89.35%
10-Year Change N/A
Growth Volatility 289.22

Charlotte's Web Holdings Inc - Net Assets Trend (2016–2024)

This chart illustrates how Charlotte's Web Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Charlotte's Web Holdings Inc (2016–2024)

The table below shows the annual net assets of Charlotte's Web Holdings Inc from 2016 to 2024.

Year Net Assets Change
2024-12-31 $27.09 Million -51.25%
2023-12-31 $55.56 Million -28.32%
2022-12-31 $77.50 Million -40.58%
2021-12-31 $130.45 Million -48.69%
2020-12-31 $254.23 Million +65.41%
2019-12-31 $153.70 Million +26.50%
2018-12-31 $121.50 Million +861.29%
2017-12-31 $12.64 Million +168.69%
2016-12-31 $4.70 Million --

Equity Component Analysis

This analysis shows how different components contribute to Charlotte's Web Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 30011100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components $328.65 Million 1213.38%
Total Equity $27.09 Million 100.00%

Charlotte's Web Holdings Inc Competitors by Market Cap

The table below lists competitors of Charlotte's Web Holdings Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Charlotte's Web Holdings Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 55,558,000 to 27,086,000, a change of -28,472,000 (-51.2%).
  • Net loss of 29,846,000 reduced equity.
  • Other factors increased equity by 1,374,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-29.85 Million -110.19%
Other Changes $1.37 Million +5.07%
Total Change $- -51.25%

Book Value vs Market Value Analysis

This analysis compares Charlotte's Web Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.46x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.59x to 0.46x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 $0.14 $0.08 x
2018-12-31 $1.30 $0.08 x
2019-12-31 $1.48 $0.08 x
2020-12-31 $1.82 $0.08 x
2021-12-31 $0.90 $0.08 x
2022-12-31 $0.51 $0.08 x
2023-12-31 $0.36 $0.08 x
2024-12-31 $0.18 $0.08 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Charlotte's Web Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -110.19%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -60.09%
  • • Asset Turnover: 0.44x
  • • Equity Multiplier: 4.19x
  • Recent ROE (-110.19%) is below the historical average (-31.32%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 13.05% 4.17% 1.78x 1.76x $143.60K
2017 59.14% 18.68% 2.06x 1.54x $6.21 Million
2018 9.72% 16.99% 0.50x 1.15x $-341.80K
2019 -10.13% -16.46% 0.42x 1.45x $-30.94 Million
2020 -18.56% -49.55% 0.31x 1.22x $-72.61 Million
2021 -105.58% -143.32% 0.56x 1.31x $-150.77 Million
2022 -76.53% -80.00% 0.40x 2.42x $-67.06 Million
2023 -42.83% -37.68% 0.41x 2.75x $-29.35 Million
2024 -110.19% -60.09% 0.44x 4.19x $-32.55 Million

Industry Comparison

This section compares Charlotte's Web Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Charlotte's Web Holdings Inc (CWBHF) $9.25 Million 13.05% 7.82x $8.94 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million